1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. Venus Medtech (Hangzhou) Inc.
  6. News
  7. Most relevant
    2500   CNE100003PJ8

VENUS MEDTECH (HANGZHOU) INC.

(2500)
  Report
Delayed Hong Kong Stock Exchange  -  04:08 2022-08-12 am EDT
15.04 HKD   +1.62%
07/13China's National Medical Products Administration Approves Venusp-Valve, Venus Medtech's In-House Developed Innovative Transcatheter Pulmonic Valve Replacement System
CI
07/13Chinese Regulator Approves Venus Medtech's Valve Replacement System
MT
06/22First American Patient Treated with VenusP-Valve™ Under Compassionate Use
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about VENUS MEDTECH (HANGZHOU) INC.
07/13China's National Medical Products Administration Approves Venusp-Valve, Venus Medtech's..
CI
07/13Chinese Regulator Approves Venus Medtech's Valve Replacement System
MT
06/22First American Patient Treated with VenusP-Valve™ Under Compassionate Use
AQ
06/22Venus Medtech Inc. Announces First American Patient Treated with VenusP-Valve Under Com..
CI
04/13Venus Medtech Completes First-in-Human Study of Bioprosthetic Heart Valve Product
MT
04/12Venus Medtech Inc. Announces Expandable Bioprosthetic Dry Tissue Valve Venus-Neo Comple..
CI
04/12Venus Medtech Wins Approval to Sell Cardiovascular Device in Europe
MT
03/31VENUS MEDTECH ANNOUNCES 2021 ANNUAL : pacesetter in China and breakthrough-maker worldwid..
AQ
03/31Venus Medtech Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
03/21Atom Semiconductor announced that it has received $15.8 million in funding from Gobi Pa..
CI
03/18Venus Medtech Inc. Appoints Shakeel Osman as Senior Vice President of Sales Europe
CI
03/18Venus Medtech appoints Shakeel Osman as Senior VP of Sales Europe to drive commercializ..
AQ
03/02Venus Medtech to Build Israel Center for New Heart Valve Technologies Development; Shar..
MT
03/01Venus Medtech Inc. Appoints Amir Gross as Head of Venus Global Heart Valve Innovation C..
CI
03/01Venus Medtech Inc. Announces Establish of Venus Global Heart Valve Innovation Center
CI
01/25Venus Medtech Concludes Acquisition of 100% Equity Interest in Cardiovalve
AQ
01/25Venus Medtech Concludes Purchase of Transcatheter Valve Maker Cardiovalve
MT
2021Venus Medtech Completes First-in-Human Study of Heart Valve Product; Shares Jump 7%
MT
2021Venus Medtech Inc. Announces Completion of Global First Clinical Application of Venus-P..
CI
2021Venus Medtech Inc. Announces Venus Vitae, Balloon-Expandable Dry Tissue Tavr System Suc..
CI
2021Venus Medtech Inc. commences an Equity Buyback Plan for 43,170,744 shares, representing..
CI
2021Venus Medtech Taking Full Ownership of Israeli Medical Device Maker Mitraltech; Shares ..
MT
2021Venus Medtech Acquires Cardiovalve to Optimize its Innovative Products Pipeline of Mitr..
PR
2021Venus Medtech in Talks With Private Healthcare Provider for Specialist Center Project; ..
MT
2021Venus Medtech Inc. Enters into Strategic Cooperation Framework Agreement with United Fa..
CI
2021VENUS MEDTECH HANGZHOU : Chinese Regulators Accept Venus Medtech's Registration Applicatio..
MT
2021Venus Medtech Announces Registration Application of TriGUARD3TM Accepted by NMPA
CI
2021Venus Medtech Inc. Announces Unaudited Consolidated Earnings Results for the Six Months..
CI
2021Venus Medtech Hangzhou Inc. Reports Earnings Results for the Half Year Ended June 30, 2..
CI
2021VENUS MEDTECH HANGZHOU : Unveils Plan to Buy Medical Device Research and Development Busin..
MT
2021VENUS MEDTECH HANGZHOU : Appoints Professor Martin B. Leon as Global Principal Investigato..
AQ
2021VENUS MEDTECH HANGZHOU : Appoints Professor Martin B. Leon as Global Principal Investigato..
PR
2021Venus Medtech Inc. Appoints Martin B. Leon as the Global Principal Investigator of RDN ..
CI
2021VENUS MEDTECH HANGZHOU : Voluntary announcement unaudited operating statistics for the per..
PU
2021Venus Medtech Inc. Announces Unaudited Group Revenue Results for the Six Months Ended J..
CI
2021Venus Medtech Inc. Announces Formation of Joint Venture Company with Healium Medical Lt..
CI
2021VENUS MEDTECH HANGZHOU : Voluntary announcement latest investment project
PU
2021VENUS MEDTECH HANGZHOU : Invests in Medical Device Manufacturer
MT
2021Hangzhou Valgen Medtech Technology Co., Ltd. announced that it has received $200 millio..
CI
2021VENUS MEDTECH HANGZHOU : Proxy form for use at the 2021 first class meeting of holders of ..
PU
2021VENUS MEDTECH HANGZHOU : Proxy form for use at the 2021 first class meeting of holders of ..
PU
2021VENUS MEDTECH HANGZHOU : Notice of 2021 first class meeting of holders of unlisted foreign..
PU
2021VENUS MEDTECH HANGZHOU : Notice of 2021 first class meeting of holders of h shares
PU
2021VENUS MEDTECH HANGZHOU : Trims Loss in 2020 as Revenue Soars 18%
MT
2021Venus Medtech Inc. Announces Change of Principal Place of Business in Hong Kong
CI
2021Venus Medtech Inc. Announces Audited Consolidated Earnings Results for the Year Ended D..
CI
2021VENUS MEDTECH HANGZHOU : Seeks $181 Million from Private Placement to Fund R&D; Shares Jum..
MT
2021VENUS MEDTECH HANGZHOU : CEP Device Completed First Clinical Application in China
MT
2021Venus Medtech Inc. Announces its CEP Device, TriGUARD3, Completes its First Clinical Ap..
CI
2021Venus Medtech Inc. Announces Change of Joint Company Secretary
CI
2020Certain H Shares of Venus Medtech Inc. are subject to a Lock-Up Agreement Ending on 10-..
CI
2020VENUS MEDTECH HANGZHOU : Wins Regulatory Nod to Sell Prosthetic Aortic Valve Product in Ch..
MT
2020National Medical Products Administration of China Approves Venus Medtech's VenusA-Plus ..
CI
2020VENUS MEDTECH HANGZHOU : Articles of association
PU
2020VENUS MEDTECH HANGZHOU : Next Day Disclosure Return
PU
2020VENUS MEDTECH HANGZHOU : Completion of placing of new h shares under general mandate and a..
PU
2020VENUS MEDTECH HANGZHOU : Taps into Surgical Heart Valve Market by Cooperating with Haoyue ..
PR
2020Venus Medtech Inc. and Jilin Changchun Haoyue Halal Meat Co., Ltd Announce the Establis..
CI
2020Venus Medtech Inc. Announces Unaudited Consolidated Earnings Results or the Six Months ..
CI
2020VENUS MEDTECH HANGZHOU : Inside information announcement approval by csrc of the company's..
PU
2020VENUS MEDTECH HANGZHOU : to Partner with Pi-Cardia to Bring its Leaflex(TM) Aortic Valve T..
PR
2020Venus Medtech Inc. to Partner with Pi-Cardia Ltd. to Bring its Leaflex(TM) Aortic Valve..
CI
2020VENUS MEDTECH INC.(SEHK : 2500) added to S&P Global BMI Index
CI
2020Certain H Shares of Venus Medtech Inc. are subject to a Lock-Up Agreement Ending on 10-..
CI
2020Venus Medtech Inc. and Opus Medical Therapies, LLC Announce Partnership for Transcathet..
CI
2020VENUS MEDTECH HANGZHOU : and Opus Medical Therapies, LLC Announce Partnership for Transcat..
PR
2020Venus Medtech Inc. Announces Unaudited Consolidated Earnings Results for the Year Ended..
CI
2020Venus Medtech Inc. Announces the Addition of Two Cardiovascular Experts to Their Adviso..
CI
2019Venus Medtech Inc. has completed an IPO in the amount of HKD 2.591738 billion.
CI
2019Venus Medtech Inc. has filed an IPO in the amount of HKD 2.5905 billion.
CI
2018Venus MedTech Inc. completed the acquisition of remaining 95.39% stake stake in Keyston..
CI
2018Venus MedTech Inc. signed an agreement to acquire remaining 95.39% stake in Keystone He..
CI
2018Venus MedTech Inc. Announces Global Advisor Board Appointments
CI
2018Venus Medtech Inc. announced that it expects to receive funding from DCP Investments
CI
2017Venus MedTech Inc. Develops and Manufactures Transcatheter Pulmonary Valve Venusp-Valve
CI
1  2Next
Upcoming event on VENUS MEDTECH (HANGZHOU) INC.